Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Survey Reveals Widespread Shortages of Cancer Medications in U.S. Healthcare System

6d ago September 10, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

The National Comprehensive Cancer Network (NCCN) has reported widespread shortages of generic cancer medications across U.S. cancer centers, with all responding centers indicating a lack of at least one anticancer agent. This situation highlights systemic issues in healthcare supply chains that could resonate in countries like Iran, where access to essential medications is also a concern.

🔍 Quick Context Guide
💡 Bottom Line: Widespread shortages of cancer medications in the U.S. highlight systemic healthcare issues that could also impact countries like Iran.

👥 Key Players

National Comprehensive Cancer Network (NCCN) MENTIONED
Alliance of leading cancer centers
"NCCN plays a crucial role in cancer treatment standards and access to medications, which can reflect similar issues in countries like Iran."
U.S. Healthcare System MENTIONED
Provider of cancer treatment
"The U.S. healthcare system's challenges can inform understanding of healthcare access issues in Iran."

📰 What Happened

The NCCN reported that all responding cancer centers in the U.S. are facing shortages of anticancer medications, with many centers lacking multiple drugs. This highlights significant supply chain issues within the healthcare system.

  • 100% of responding cancer centers reported shortages of at least one anticancer agent.
  • Over 20% of centers are experiencing shortages of five or more different medications.

💡 Why It Matters

🇮🇷 For Iran: The shortages in the U.S. may resonate with Iran, where access to essential medications is already a critical issue due to sanctions and economic challenges.
🌍 Regional: Other countries in the region may face similar healthcare supply chain issues, affecting cancer treatment availability.
🌐 International: This situation may prompt discussions about global healthcare supply chains and the need for reforms.

📚 Background

Cancer medication shortages are a growing concern in many healthcare systems, often linked to manufacturing issues, regulatory challenges, and economic factors.

Healthcare supply chain management Access to medications in developing countries
📡 Source: NEUTRAL
📊 Confidence: 70%
The NCCN is a reputable organization, and their findings are based on survey data from cancer centers, making this information credible.

The National Comprehensive Cancer Network (NCCN)—an alliance of leading cancer centers—has published updated data on the current impact of generic cancer medication shortages in the United States. The data come from survey responses from pharmacy directors and other clinical and administrative leaders at NCCN Member Institutions from late August. According to the results, 100% of responding cancer centers are experiencing a shortage of at least one anticancer agent, with more than 20% of centers currently experiencing shortages of five or more different medications.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →